Dogwood Therapeutics, Inc.

NASDAQ:DWTX

Biotechnology

Healthcare
$1.52 +2.22%

+$0.04 today

Market cap
$51.12M
Beta
1.76
P/E (TTM)
-0.2
EPS (TTM)
-$0.84
52W Low $1.28High $9.50

Volume 0.12M

Average 0.09M

Balance Sheet

Inspect the capital base behind the business.

Assets

$90.17M

FY 2025 · Annual

-4.4% YoY

Liabilities

$15.27M

FY 2025 · Annual

-49.1% YoY

Equity

$74.90M

FY 2025 · Annual

+16.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents14.01M7.03M3.32M14.85M6.52M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets8637.29K3.56K28.01K4.88K
Total Current Assets15.78M8.37M4.17M16.54M8.43M
Property, Plant & Equipment (Net)000222.65K194.93K
Goodwill00011.81M12.4M
Intangible Assets00065.71M68.99M
Long-term Investments00018.13K0
Tax Assets00000
Other Non-current Assets0000158.96K
Total Non-current Assets00077.76M81.74M
Total Assets15.78M8.37M4.17M94.31M90.17M
Account Payables353.86K573.16K111.91K1.23M760.95K
Short-term Debt00049.7K0
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities532.68K159.7K0687.59K745.08K
Total Current Liabilities1.28M1.04M358.55K3.18M3.06M
Long-term Debt00015.38M0
Deferred Tax Liabilities00011.31M12.11M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities00026.85M12.22M
Total Liabilities1.28M1.04M358.55K30.03M15.27M
Common Stock8331.83K771332.97K
Retained Earnings(43.93M)(56.17M)(61.47M)(73.82M)(108.08M)
Accumulated OCI000(3.86M)(587.04K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity14.5M7.33M3.81M64.28M74.9M
Total Debt00015.59M162.6K
Net Debt(14.01M)(7.03M)(3.32M)737.71K(6.36M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$13.2M
Other Current$1.8M
Total Current Assets$15.0M
PP&E (Net)$159.3K
Goodwill$12.2M
Intangible Assets$67.8M
Other Non-current$18.7K
Total Non-current Assets$80.2M
Total Assets$95.2M

Analysis

Selected assets total $95.2M for Latest. The largest visible component is Intangible Assets at $67.8M, about 71.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 7, 2025
8-KCurrent reportNov 6, 2025
DEF 14ADEF 14A filingOct 20, 2025
S-3/AS-3/A filingOct 16, 2025
DEFA14ADEFA14A filingOct 9, 2025

How much cash does DWTX have?

Dogwood Therapeutics, Inc. (DWTX) reported $6.52M in cash and equivalents in fiscal 2025.

How much debt does DWTX carry?

Dogwood Therapeutics, Inc. (DWTX) reported $162,604.00 of total debt, with net debt of -$6.36M.